Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: ESAIY ) 8.260 +0.060 (+0.73%) Streaming Delayed Price Updated: 3:59 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ESAIY < Previous 1 2 Next > Biogen's Make-Or-Break Moment Is Here In Alzheimer's Treatment July 06, 2023 The FDA is expected to announce Thursday whether it has approved or rejected Biogen's Alzheimer's drug. Via Investor's Business Daily Biogen Stock Halted As It Faces Make-Or-Break Moment For Alzheimer's Treatment June 09, 2023 A panel of experts will debate the merits of Biogen's drug, Leqembi. Via Investor's Business Daily Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near June 07, 2023 The FDA's advisors will consider the full approval of Leqembi on Friday. Via Investor's Business Daily Biogen Hits Buy Zone On A Fresh Win In Alzheimer's Disease; Eli Lilly, Eisai Shares Jump June 01, 2023 The news also benefits Biogen's partner Eisai and rival Eli Lilly. Via Investor's Business Daily Eli Lilly's Alzheimer's Drug Is Just Version 1.0. But It's Still On Track For Blockbuster Status, Analyst Says. May 15, 2023 An analyst says Lilly's donanemab could become a blockbuster in its second year on the market. Via Investor's Business Daily Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC May 13, 2023 Bliss Biopharma may out-license global rights for its HER2 ADC to Eisai Pharma in a deal with a potential value of $2 billion. Also, Junshi Bio out-licensed regional rights for its anti-PD-1 mAb to Dr.... Via Talk Markets IBD 50 Leader And No. 1 Biotech Catalyst Puts Up 128% Earnings Growth May 11, 2023 Though Catalyst's unadjusted earnings missed forecasts, they grew by triple digits. Via Investor's Business Daily Alzheimer's Drugs Still Aren't Biogen's Saving Grace — But The Company Is Hopeful April 25, 2023 The company is hopeful for maintenance dosing and a new injection of the drug. Via Investor's Business Daily 3 Stocks to Buy That Could Be the Next Biotech Breakthrough April 16, 2023 Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios. Via InvestorPlace The 3 Best Millionaire-Maker Stocks to Buy for April 2023 April 07, 2023 These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. Via InvestorPlace 7 A-Rated Stocks to Buy for April 2023 April 07, 2023 Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape. Via InvestorPlace 7 Core Stocks to Build a Solid Portfolio Around March 13, 2023 You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation. Via InvestorPlace 7 Smart Stock Picks for Cautious Investors February 28, 2023 As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors. Via InvestorPlace < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
